| 000 | 01141nam a2200205Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625160141.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-15907 | ||
| 245 | 1 | 0 | _aAntifungal drugs: Targeting histone acetylation |
| 490 | 0 | _vNature Reviews Drug Discovery, 9, p.680-681, 2010 | |
| 520 | 3 | _aThe fungal pathogen Candida albicans causes serious infections in immunocompromised individuals, and although treatment is possible using azole or echinocandin drugs, their efficacy can be compromised by the emergence of drug-resistant strains. Writing in Nature Medicine, Wurtele and colleagues show that fungal enzymes that regulate histone acetylation - specifically the acetylation of lysine 56 on histone H3 (H3K56ac)- could be new targets for the treatment of C. albicans | |
| 650 | 1 | 4 | _aCANDIDA ALBICANS |
| 650 | 1 | 4 | _aFUNGALS |
| 650 | 1 | 4 | _aPATHOGENS |
| 700 | 1 | 2 | _aHarrison, Charlotte |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/14q9blOnZXpjZBB22Ghdd1Rei3qIyBsCJ/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c50083 _d50083 |
||